help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0120
Molecular Endocrinology Vol. 0, No. 2003 200301201-
doi:10.1210/me.2003-0120
Copyright © 2003 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
17/10/1931    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Frank, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Frank, S. J.

Submitted on April 4, 2003
Accepted on June 19, 2003

Reduced Proteolysis of Rabbit GH Receptor Substituted with Mouse GH Receptor Cleavage Site

Xiangdong Wang1, Kai He1, Mary Gerhart1, Jing Jiang1, Raymond J. Paxton1, Ram K. Menon1, Roy A. Black1, Gerhard Baumann1, and Stuart J. Frank1*

1 Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, and Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL; Amgen Incorporated, Seattle, WA; Department of Pediatrics, University of Michigan, Ann Arbor, MI; Center for Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Medical School, and the Veterans Administration Chicago Health System, Lakeside Division, Chicago, IL; Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, AL

* To whom correspondence should be addressed. E-mail: frank{at}endo.dom.uab.edu.

GH binding protein (GHBP) is a circulating form of the GH receptor (GHR) extracellular domain, which derives by alternative splicing of the GHR gene (in mice and rats) and by metalloprotease-mediated GHR proteolysis with shedding of the extracellular domain as GHBP (in rabbits, humans, and other species). Inducible proteolysis of either mouse (m) or rabbit (rb) GHR is detected in cell culture in response to phorbol ester and other stimuli, yielding a cell associated GHR remnant (comprised of the cytoplasmic and transmembrane domains and a small portion of the proximal extracellular domain) and downregulating GH signaling. In this report, we map the mGHR cleavage site by adenoviral overexpression of a membrane-anchored mGHR mutant lacking its cytoplasmic domain and purification and N-terminal sequencing of the PMA-induced remnant protein. The sequence obtained was LEACEEDI, which matches the mGHR extracellular domain stem region sequence L265EACEEDI272, indicating that mGHR cleavage occurs in the extracellular domain nine residues outside of the transmembrane domain, in the same region (but at different residues) as the rbGHR cleavage site we recently mapped. We studied the effects on receptor proteolysis and GHBP shedding of replacing rbGHR cleavage site residues with those corresponding to the mGHR cleavage site. We analyzed five separate "rodentized" rbGHR mutants incorporating mGHR amino acids either at or surrounding the cleavage site. Each mutant was normally processed, displayed at the cell surface, and responded to GH stimulation by undergoing tyrosine phosphorylation. Only the mutants replaced with mGHR cleavage site residues, rather than surrounding residues, exhibited deficient inducible proteolysis and GHBP shedding. These findings suggested that the GHR cleavage sites in the two species differ in their susceptibility to cleavage. This difference may underlie interspecies variation in utilization of proteolysis to generate GHBP.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
X. Wang, J. Jiang, J. Warram, G. Baumann, Y. Gan, R. K. Menon, L. A. Denson, K. R. Zinn, and S. J. Frank
Endotoxin-Induced Proteolytic Reduction in Hepatic Growth Hormone (GH) Receptor: A Novel Mechanism for GH Insensitivity
Mol. Endocrinol., June 1, 2008; 22(6): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
G. Cao, H. Lu, J. Feng, J. Shu, D. Zheng, and Y. Hou
Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population
Jpn. J. Clin. Oncol., April 1, 2008; 38(4): 308 - 316.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Loesch, L. Deng, X. Wang, K. He, J. Jiang, and S. J. Frank
Endoplasmic Reticulum-Associated Degradation of Growth Hormone Receptor in Janus Kinase 2-Deficient Cells
Endocrinology, December 1, 2007; 148(12): 5955 - 5965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Asa, R. DiGiovanni, J. Jiang, M. L. Ward, K. Loesch, S. Yamada, T. Sano, K. Yoshimoto, S. J. Frank, and S. Ezzat
A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors
Cancer Res., August 1, 2007; 67(15): 7505 - 7511.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Yang, X. Wang, J. Jiang, and S. J. Frank
Role of the Growth Hormone (GH) Receptor Transmembrane Domain in Receptor Predimerization and GH-Induced Activation
Mol. Endocrinol., July 1, 2007; 21(7): 1642 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Deng, K. He, X. Wang, N. Yang, C. Thangavel, J. Jiang, S. Y. Fuchs, and S. J. Frank
Determinants of Growth Hormone Receptor Down-Regulation
Mol. Endocrinol., July 1, 2007; 21(7): 1537 - 1551.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. J. Frank, X. Wang, K. He, N. Yang, P. Fang, R. G. Rosenfeld, V. Hwa, T. R. Chaudhuri, L. Deng, and K. R. Zinn
In Vivo Imaging of Hepatic Growth Hormone Signaling
Mol. Endocrinol., November 1, 2006; 20(11): 2819 - 2830.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Loesch, L. Deng, J. W. Cowan, X. Wang, K. He, J. Jiang, R. A. Black, and S. J. Frank
Janus Kinase 2 Influences Growth Hormone Receptor Metalloproteolysis
Endocrinology, June 1, 2006; 147(6): 2839 - 2849.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. He, K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank
Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor
Endocrinology, November 1, 2005; 146(11): 4755 - 4765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Cowan, X. Wang, R. Guan, K. He, J. Jiang, G. Baumann, R. A. Black, M. S. Wolfe, and S. J. Frank
Growth Hormone Receptor Is a Target for Presenilin-dependent {gamma}-Secretase Cleavage
J. Biol. Chem., May 13, 2005; 280(19): 19331 - 19342.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Jiang, X. Wang, K. He, X. Li, C. Chen, P. P. Sayeski, M. J. Waters, and S. J. Frank
A Conformationally Sensitive GHR [Growth Hormone (GH) Receptor] Antibody: Impact on GH Signaling and GHR Proteolysis
Mol. Endocrinol., December 1, 2004; 18(12): 2981 - 2996.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho
Estrogen Regulation of Growth Hormone Action
Endocr. Rev., October 1, 2004; 25(5): 693 - 721.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society